Novavax (NVAX) Files For UK Authorization of its COVID-19 Vaccine

Go back to Novavax (NVAX) Files For UK Authorization of its COVID-19 Vaccine
Novavax, Inc. (NASDAQ: NVAX) Delayed: 9.09 +0.06 (0.66%)
Previous Close $9.03    52 Week High $9.23 
Open $9.14    52 Week Low $1.16 
Day High $9.30    P/E N/A 
Day Low $9.05    EPS $-0.30 
Volume 252,862